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POPULÄRVETENSKAPLIG SAMMANFATTNING 
Streptococcus pneumoniae (pneumokocker) är en av de bakterier som orsakar lung-
inflammation och kan även leda till bakteriell blodförgiftning och hjärnhinneinflammation. 
Tack vare den tilltagande användningen av antibiotika samt vaccinernas intåg har 
sjukdomarna föranledda av denna bakterie kunnat stävjas. Men på senare tid har dödsfallen 
ökat i antal och tidigare relativt lättbehandlade infektioner orsakade av bakterien har blivit en 
större utmaning. En av anledningarna till att pneumokocker återigen börjat bli en allvarlig 
hälsorisk är att antibiotikaresistensen ökat avsevärt. För att kunna utveckla nya vacciner och 
läkemedel behövs måltavlor för dessa, i detta fall något som kallas för virulensfaktorer. 
Bakterien använder sig av virulensfaktorer för att kunna infektera oss människor eller för att 
skydda sig mot vårt immunförsvar. De bidrar till bakteriens virulens, vilket är dess förmåga 
att orsaka sjukdom. Dessa virulensfaktorer är i många fall proteiner som sitter på ytan av 
bakterien. 
En av grundstenarna i att kunna utveckla vaccin och läkemedel mot helt nya måltavlor, är att 
ta reda på så mycket som vi kan om dem, hur de fungerar och hur de ser ut. För att kunna ta 
reda på detta använder vi oss av en process som kallas strukturbestämning. I detta använder 
vi olika tekniker för att skapa en väldigt detaljerad 3D-modell av t.ex. ett protein. Detta måste 
göras eftersom proteiner är för små att se med ett mikroskåp. 
Målet med forskningen som ingår i den här avhandlingen är att strukturbestämma och 
karakterisera två proteiner som är viktiga för pneumokockers virulens, PsrP och RrgC. PsrP 
sitter på ytan av baketerien och fungerar som ett lim, i det att den hjälper bakterien att fästa 
till ytor, som t. ex. vår lungvävnad. Endast en liten del av detta protein är funktionellt, och 
denna del har vi bestämt strukturen på. Det visar sig att denna del binder till ett protein som 
heter Keratin-10. Många känner säkert till keratin, hornämne, som en viktig komponent i 
naglar och framförallt hår. Det som var intressant med att finna att PsrP binder till Keratin-10, 
är att det i vissa fall finns på ytan av lungceller. Det är ännu oklart om dessa fall inkluderas av 
infektion av pneumokocker, men om detta visar sig vara fallet betyder det ett stort 
genombrott för bekämpning av bakterien. RrgC är ett protein som ingår som en del av den 
struktur på bakterien som kallas pilus, som är ett vidhäftningsorgan. Inte mycket har varit 
känt om detta protein, men det har nu strukturbestämts och dessa studier kommer 
förhoppningsvis att leda till att nya läkemedel samt vacciner kan utvecklas för att återfå 
kontrollen över denna bakterie. 
 
  
  
ABSTRACT 
Streptococcus pneumoniae (pneumococcus) is a major human pathogen and a leading cause 
of morbidity and mortality worldwide, especially in children and the elderly. The casualties 
due to respiratory infections are estimated to be over 4 million per year, where pneumococcus 
is the predominant species. Moreover, the increasing number of antibiotic-resistant strains 
and the suboptimal clinical efficacy of available vaccines confines control of this pathogen. 
In view of this situation, substantial attention has focused on novel virulence-related 
pneumococcal proteins as potential targets for future drug targets. One such target is the 
pneumococcal serine-rich repeat protein (PsrP), an important virulence factor present in a 
majority of the strains capable of causing invasive pneumococcal disease (IPD). The 
functional binding region (BR) of this protein binds to keratin-10 (KRT10) and also promotes 
biofilm formation through self-oligomerization. The crystal structure of the KRT10-binding 
region of PsrP (BR187-385) reveals an extended β -sheet on one side of a compressed two-sided 
β-barrel presents a basic groove that could accommodate the acidic helical rod domain of 
KRT10. Well-ordered loop regions distort the other side of the barrel and form a paperclip-
like sub-structure for more specific interaction with KRT10. In vitro alanine substitution of 
residues localized within this paperclip structure efficiently disrupted BR187-385/KRT10 
complex formation. 
Within the work of this thesis we also found that BR187-385, which lacks the putative 
oligomerization region, forms stable oligomers in vitro. Small angle X-ray scattering and 
circular dichroism experiments revealed a non-globular and possibly disordered structure of 
the N-terminal region. A comparative analysis of the long (BR120-395) and short (BR187-385) 
domain constructs even suggested an inhibitory role for the N-terminal BR122-166 domain in 
oligomerization. Indeed, we could show that the N-terminal region is released by cleavage 
through the human furin protease that specifically recognizes a sequence localized between 
the globular BR187-385 domain and the disordered N-terminal part. The crystal structure of the 
dimer of the KRT10-binding domain of PsrP reveals a domain swap mechanism for 
dimerization, this process, although energetically costly, is probable when PsrP is involved in 
biofilm formation. 
The minor ancillary pilus protein RrgC is believed to anchor the pneumococcal pilus to the 
cell wall, and until recently very little was known about its structure. In this work we have 
evaluated the structure of the protein in solution with SAXS, and shown that the protein is a 
multidomain protein with flexible linkers and adopts extended conformations in solution.  
Through this work we have proposed a more specific interaction between PsrP and KRT10 
than previously reported, as well as shown that oligomerization is possible despite the 
removal of the N-terminal region. These findings are very important for a deeper 
understanding of the details in PsrP’s role in pneumococcal invasion. The structural studies of 
RrgC provide a platform for future studies. The results presented within this thesis will 
hopefully aid in the future development of novel drugs and vaccines. 
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1 INTRODUCTION 
1.1 Streptococcus pneumoniae: “THE CAPTAIN OF ALL THE MEN OF 
DEATH”  
The statement in the title above was Sir William Osler’s description of Streptococcus 
pneumoniae (pneumococcus), in 1918, and it is as fitting today as it once was (1, 2). The 
human pathogen S. pneumoniae is an inhabitant of the upper respiratory tract in about 10-
20% of healthy adults and 40-60% of children (2, 3). Pneumococcus, although normally 
commensal, can cause sinusitis and otitis media as well as more sinister conditions such as 
pneumonia, bacteremia and meningitis and is a major cause of morbidity and mortality 
worldwide (4, 5). Unlike other commensals, such as Streptococcus pyogenes and 
Staphylococcus aureus, pneumococcus produces a rather limited repertoire of tissue-
destructive proteins and toxins, making it an ideal candidate for the study of factors 
contributing to pathogenicity (3). 
Historically, the study of S. pneumoniae has contributed greatly to the fields of molecular 
biology and epidemiology. Louis Pasteur and George M. Sternberg, independently of one 
another, first described this organism in 1881, leading to it being established as a major cause 
of human lobar pneumonia. Being a pervasive pathogen, pneumococcus was one of the first 
bacteria observed during the development of the Gram staining technique, which was key in 
being able to distinguish pneumococcal pneumonia from other causes. In the beginning of the 
20th century, Fred Neufeld demonstrated agglutination as well as capsular swelling when 
adding specific antisera to pneumococcal suspensions, thus providing a method for 
serotyping of pneumococcal isolates. The discovery by Neufeld, through Fred Griffith, led 
Oswald Avery and colleagues to demonstrate that the natural transformation of 
pneumococcus occurs with the DNA as genetic material. This was shown by transformation 
of a noncapsulated, avirulent strain of S. pneumoniae with the DNA from a capsulated, 
virulent strain (1, 3, 6). Thence, the studies of this bacterium has led to the sprouting of a 
whole body of knowledge leading to important discoveries and state-of-the-art techniques 
used by laboratories across the world. 
S. pneumoniae is a Gram-positive bacterium, most commonly seen as diplococcus, and is 
able to divide without separation of the cell walls, resulting in a continuous growth with the 
formation of a string of cells (7). The S. pneumoniae strains are categorized into subgroups, 
serotype strains, depending on the composition of their polysaccharide capsule. The surface 
capsular polysaccharide, a key pathogenicity factor, is composed of repeating units of sugars 
(8). In the early 1920s Michael Heidelberger and colleagues demonstrated that this complex 
carbohydrate, capsular polysaccharide (CPS), was antigenic by vaccination of mice. This 
novel finding changed the field as it up until that point was generally believed that only 
proteins were able to elicit an immune response (1, 6, 8). There are 93 serotypes of S. 
pneumonia that have been described so far and whose genomes can have up to 10% sequence 
variation (1, 5, 9). In order to investigate the genetic basis of pneumococcal virulence, two 
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serotype strains of S. pneumoniae were chosen to have their genomes fully sequenced, 
virulent serotype 4 (TIGR4) and the avirulent R6 (6, 10). The genomes of these strains were 
compared in order to identify genes associated with virulence. The main difference between 
these strains is the fact that TIGR4 is capsulated whilst R6 is not, and the capsule has since 
long been acknowledged as a major virulence factor of pneumococcus (1, 3, 6, 11). Analysis 
of the genome of TIGR4 is widely used to identify components involved in virulence, such as 
surface proteins. Examples are pneumococcal surface protein (pspA), the autolysin (lytA) as 
well as choline binding proteins (CBPs), adhesins, such as pneumococcal serine-rich repeat 
protein (PsrP) and the pneumococcal pilus. The importance in characterizing novel virulence 
factors is the potential use they may have as novel drug and vaccine targets (11). 
1.2 PNEUMOCOCCAL EPIDEMIOLOGY 
Pneumococcus colonizes the human nasopharynx during the first months of life, and is 
generally believed to spread via aerosols. The nasopharynx acts as a reservoir for 
pneumococci and is the source of pneumococcal spread between human hosts. After the 
bacteria enter the nasal cavity and adhere to nasopharyngeal epithelial cells, they can colonize 
the nasal cavity, rendering the host a carrier. This colonization is usually cleared quite rapidly 
resulting in serotype-specific immunity, however when this clearance fails it can cause upper 
respiratory tract infections ore even more severe disease by spreading to other organs 
resulting in pneumonia, bacteremia, or even meningitis (9, 12). Occurrence of invasive 
pneumococcal disease varies significantly based on age, immune status, socioeconomic status 
and geography, among other factors. The serotypes associated with invasive disease vary 
between geographical areas. This is very important to consider, since the vaccines available 
are serotype-specific (2, 9).  
From studies of animal models it is evident that the nasopharynx carriage is the first step in 
pneumococcal pathogenesis. These studies demonstrates the development of otitis media or 
invasive disease following nasal inoculation of pneumococci (4). Carriage is associated with 
colonization of one serotype at a time, although it is also common with multiple serotype 
carriage. The natural competence displayed by S. pneumoniae lead to the possibility of a 
switch of capsular serotype through the uptake of extracellular DNA. This means that other 
techniques than serotyping are required to distinguish clinical isolates, referred to as clonal 
types, from one another. These molecular techniques are used to analyze the genetic 
relationships between clonal types. The most common colonization occurs with an “either/or” 
host-pathogen interaction, in that it is either a clonal type with a invasive pneumococcal 
disease phenotype, or one with a non-invasive phenotype that allows for long-term carriage, 
although it must be noted that it is very rare with serotypes causing carriage alone (2, 9). 
Current means of controlling this pathogen are vaccines directed towards the polysaccharide 
capsule and β-lactam based antibiotics. The resistance rates of S. pneumoniae to conventional 
antimicrobiotics have increased, which means that failures in treatment of patients with 
pneumococcal infections occur more frequently (13). This emphasizes the need for the 
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development of novel drugs and vaccines against pneumococcus. As previously mentioned, 
the pneumococcal CPS is highly immunogenic and induces type-specific protective 
immunity, and the vaccines are based on the polysaccharidic capsule, which differs between 
serotypes (14, 15). The first polyvalent CPS vaccines were licensed in the 1970s and the 
current 23-valent one is used in the United States and Europe. This vaccine covers the most 
common disease causing serotype strains in these parts of the world, however CPS vaccines 
fail to elicit a proper immune response in young children (< 2 years of age), since CPSs are 
T-cell-independent. Many bacterial pathogens carry surface antigens that are T-cell-
independent, which means that they are able to stimulate antibody production without help 
from T-cells, and polysaccharide antigens is one of them (16, 17). Pneumococcal CPS-
protein conjugate (PCV) vaccines were developed to overcome this shortcoming. The 
coupling of CPS to protein transporters renders them T-cell-dependent antigens (5, 14, 18-
20). The serotypes included in the conjugate vaccines were chosen because their dominance 
in invasive diseases in the United States, thus they are not adapted to geographic areas 
displaying different serotype distributions. At the moment there are 7-, 10- and 13-valent 
vaccines in use.  
The reason for the lower number of serotypes included so far in the conjugate vaccines are 
high costs due to technical reasons. Since the year 2000, when the 7-valent vaccine was 
included in the childhood vaccination program in the United States, there was an enormous 
decrease in pneumococcal invasive disease (vaccine-serotype-related) in children. Herd 
immunity in the adult population has also reduced carriage of vaccine-serotypes. However, it 
has been recently reported that serotypes reduced by the vaccines available are being replaced 
by non-vaccine pneumococcal serotypes (serotype replacement). The increase in these 
replacement strains has brought new concern combined with the observed clonal expansion 
of non-vaccine clones, as capsular switching may eradicate the efficacy in existing vaccines. 
Discussions are ongoing as to whether or not it is cost-effective to vaccinate adults with the 
conjugate vaccine because the 23-valent polysaccharide vaccines effectiveness towards non-
bacteremic pneumococcal pneumonia (NPP) appears to be poor. Nonetheless, it is suggested 
conjugate vaccines might be effective against NPP and invasive pneumococcal disease (IPD) 
in adults. This is still a contentious issue because, as of yet, the potential effectiveness is 
unknown, and routine vaccination of children will most likely result in herd immunity, 
reducing the potential benefits from adult vaccination (9, 14, 19-22).  
The standard treatment of infections caused by pneumococci has been the β-lactam penicillin 
for a very long time. The general use of antibiotics to combat these infections is in the long-
term unrealistic due to the raise in antibiotic resistances through genetic plasticity including 
natural competence the sole use of antibiotics will become less and less effective. Some 
pneumococcal clonal types carrying resistance are more inclined to spread globally than 
others. One example is the clonal type ST156 (resistance towards penicillin, trimethoprim 
sulfamethoxazole) that originated in Spain and has now spread to other countries (9, 23). The 
widespread resistance towards most antibiotics observed continues to be a cause for concern. 
The spread of antibiotic-resistant strains, together with the observed serotype-replacement 
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and capsular type switching emphasizes the need to develop improved vaccines and drugs.  
A biofilm is a bacterial formation where a community of microorganisms adhered to a 
surface are embedded in a matrix consisting of extracellular material. The microorganisms 
themselves mostly produce the components of this matrix, which can constitute up to and 
over 90% of the biofilm. The biopolymers that make up the scaffold of the matrix are referred 
to as extracellular polymeric substances (EPS), which allow for surface adhesion and biofilm 
cohesion (24).  
Up until quite recently, no information about pneumococcal biofilms was available, however, 
it is now evident that pneumococci can form biofilms, particularly during colonization, and in 
the middle ear (otitis media). More than 60 % of human infections by S. pneumoniae are 
related to the formation of pneumococcal biofilms, and these bacterial communities have 
been proven to have an increased tolerance towards the host immune system as well as 
antibiotics. It has been shown that changes in gene-expression and production of specific 
virulence factors are more abundant during biofilm-formation. These include pneumolysins, 
CBPs and PsrP (18, 25). 
1.3 PNEUMOCOCCAL VIRULENCE FACTORS: SURFACE MOLECULES 
The ever-growing knowledge of the genomes of both invasive and non-invasive strains of S. 
pneuomoniae has enabled detailed comparative analyses. The differences in genomes 
between strains are located within sites of diversity scattered around the bacterial 
chromosome, which mainly distinguishes invasive from non-invasive strains. Many of these 
regions carry the genetic signature of pathogenic islands (2, 3). It’s been established that S. 
pneumoniae, as a species, show a high plasticity and variability in its genome, most likely 
due to recombinational events, both within and between strains, as well as transformation 
events (26).  
In order for tissue invasion by pneumococcus to be successful, a battery of virulence factors 
needs to be expressed in a coordinated fashion. The most important virulence determinants of 
pneumococcus includes the capsular polysaccharides (adherence and antiphagocytic 
properties), adhesins, invasion genes, heavy-metal transporters, oxidative stress protectors, 
host-defence evasion molecules and biofilm formatting compounds, among others (2). The 
initial adherence of pneumococci to nasopharyngeal cells is crucial, however, the 
mechanisms are not fully understood. Although not exclusively involved in adhesion, the 
surface molecules of pneumococci are undoubtedly required in adhesion and colonization 
(27, 28).  
Considering the increased prevalence of strains resistant to currently available treatments 
the situation with antibiotic resistance and serotype switching progresses, which means it is 
absolutely necessary for the development of new therapies. In order to make this challenging 
task more feasible we need a deeper understanding of the interaction between this pathogen 
and the host tissues. These interactions mainly involve extracellular virulence factors 
  5 
expressed by the bacterium, to interact with host tissues. Such virulence factors include the 
sugar-based (capsule, teichoic and lipoteichoic acids) and the protein based (29). 
 
1.3.1 Pneumococcal serine-rich repeat protein (PsrP) 
PsrP is a recently identified host surface and intraspecies bacterial adhesion, a pneumococcal 
virulence factor that is encoded within the RD10 pathogenicity island and present in 60 % of 
strains capable of causing pneumonia in children (30, 31). PsrP is an extremely large surface 
protein, which belongs to the serine rich repeat protein (SRRP) family, and as the name 
suggests consists largely of repeats of the amino acid serine. SRRPs are glycosylated and thus 
runs larger on SDS-PAGE than their expected molecular weight (MW), and this is also the 
case with PsrP (32). The domain structure of SRRPs typically comprises an N-terminal signal 
peptide, a shorter serine-rich repeat region (SSR2), a non-repeating region (NR) that is unique 
for different SRRPs followed by a very long serine-rich repeat region (SSR1) and a cell wall 
anchor (CWAD). The extremely long SSR2 domain is believed to extend the functional NR 
domain away from the bacterium to mediate adhesion (33, 34). The domain organization of 
PsrP is outlined in figure 1. 
 
Figure 1. Domain organization of PsrP, the NR domain of PsrP is called the basic region (BR) (35) 
With its 4776 amino acid residues, PsrP is the largest known bacterial protein. The functional, 
unique domain, NR, of PsrP is named the basic region (BR), simply because of its high 
content of basic amino acids, and a predicted isoelectric point of 9.9 (32). PsrP is able to 
mediate the adherence to lung (bronchial and alveoliar) cells but not to nasopharyngeal or 
vascular endothelial cells. Studies have shown that S. pneumoniae mutants that are deficient 
in psrP have greatly reduced virulence (30, 36).  Pneumococci that do not express PsrP are 
incapable of establishing a lung infection in mouse models (32, 37). 
Quite recently, the host ligand of PsrP has been identified as KRT10, which has been shown 
to be overexpressed on lung cells in certain cases. Immunization with the BR domain of PsrP 
protects mice against pneumococcal infection, which means that the BR domain, or 
derivatives there of, might be suitable as a component in a protein vaccine to protect against 
pneumococcal disease. The location of the KRT10 binding region is indicated in figure 1 
(32). PsrP has also been proposed to be of importance in pneumococcal aggregation and 
biofilm formation. In vivo studies have shown that psrP deficient mutants were unable to 
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form pneumococcal aggregates, and the oligomerization region was suggested to be situated 
in the N-terminal region of BR (figure 1) (25).  
1.3.2 The pneumococcal pilus  
The bacterial pilus is an extended polymer structure coupled to the cell wall. Pili are long 
hair-like extensions that commonly have adhesins attached to the tip, to maximize contacts 
with the surroundings. The Gram-positive pilus differs from the Gram-negative pilus in that 
the subunits making up the structure are covalently attached to one another, and require 
sortase enzymes for proper assembly. The Gram-negative pili, on the other hand, require 
specific chaperons for proper assembly (38-40). 
The subunits of the Gram-positive pilus are secreted through the cell membrane, after which, 
polymerization takes place. The polymerization is catalyzed by sortases (Srt), a family of 
membrane-associated transpeptidases, which covalently couple proteins containing a C-
terminal cell-wall sorting signal (CWSS), to the peptidoglycan cell wall, or to each other. The 
housekeeping sortase, SrtA, anchors the surface molecules, containing the CWSS followed 
by a hydrophobic segment and a positively charged tail, and is present in nearly all Gram-
positive bacteria. The sortases cleaves the precursor-protein through a recognition peptide, 
the LPXTG (or LPXTG-like, where X is any amino acid) motif between T and G, after which 
the protein is coupled to its target. The pili expressed in different bacteria are always co-
expressed with the family of sortases that assemble them, (class C sortases), and are 
components of the pilus islet in the genome (38, 41-43). 
1.3.2.1 The pneumococcal pilus is composed of RrgA, RrgB and RrgC 
S. pneumoniae strain T4 (TIGR4) expresses a pilus, encoded by the rlrA pilus islet 1. The 
pneumococcal pilus consists of three different component proteins. RrgA, RrgB and RrgC. 
These are covalently coupled by the pilus-specific sortases in pneumococcus (SrtC-1, SrtC-2 
and SrtC-3) and anchored to the peptidoglycan cell wall by the housekeeping SrtA. The 
recognition peptides (LPXTG-like motif) for RrgA, RrgB and RrgC are YPRTG, IPQTG and 
VPDTG, respectively (43, 44). Covalently linked repeating units of the major component, 
RrgB, make up the stalk of the pilus. The structure of the first three domains was determined 
by X-ray crystallography in 2010 (45), and, subsequently fully determined in 2011 (46-48). 
RrgB consists of four domains (D1-D4) (Figure 2); each domain is stabilized by one 
intramolecular isopeptide bond, present in all subunits of the pilus. An isopeptide bond is an 
amide bond that can be formed autocatalytically between the amino acids lysine and 
asparagine, which is typically stabilized by aspartic acid or glutamic acid. This bond can form 
within proteins and prior to its discovery in Gram-positive pilin subunits this had never been 
observed (49). RrgA acts as an adhesin that can bind to lung epithelial cells in vitro, which is 
aided by its location at the tip of the pilus, though it was shown to also assemble along the 
shaft (41, 50-53). However, more recently converse reports show that RrgA is only localized 
at the tip of the pilus (54). The crystal structure of RrgA reveals it to be composed of four 
domains (D1-D4, Figure 2), where D2 and D4 are stabilized by one intra-domain isopeptide 
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bond each. The crystal structure also unveiled an integrin collagen-recognition domain, 
confirming its ability to recognize and bind extracellular matrix elements (55).  
 
Figure 2. Crystal structure of RrgB (upper panel), with domains D1-D4, PDB ID: 2Y1V (47). The 
bottom panel show the crystal structure of RrgA, with domains D1-D4, PDB ID: 2WW8 (55). Figures 
generated using PyMOL (56) 
The last, and also the smallest, building block of the pneumococcal pilus is the minor 
ancillary protein RrgC. The information about the role of RrgC in the virulence of the pilus is 
limited, however, it is now generally accepted that the protein is anchoring the pilus to the 
peptidoglycan cell wall of S. pneumoniae. There is continuing interest into which of the three 
pilus-related sortases are coupling RrgC to the rest of the pilus structure, as none of the 
sortases seem to identify the recognition peptide (VPDTG) specifically (43, 44). Therefor, 
there is a great incentive to structurally characterize this protein to shed insights into its 
functions, as well as the mechanism of its coupling to the cell wall. Structural information 
was lacking for RrgC when this work was initiated. However, recently the structure of a 
modified RrgC has been determined (35) revealing a three-domain structure (D1-D3) (Figure 
3) with intra-domain stabilizing isopeptide bonds in D2 and D3. The study suggests that 
RrgC is mostly dependent on the housekeeping sortase, SrtA, for covalent linking to the 
peptidoglycan cell wall.  
 
Figure 3. Crystal structure of RrgC, PDB ID: 4OQ1 (35). Figure generated using PyMOL (56) 
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1.4 HOST RECOGNITION AND IMMUNOLOGY 
Adherence of S. pneumoniae to the alveolar epithelium following proliferation and initiation 
of host damage responses leads to the development of lobar pneumonia. During the early 
stages of host response, which is an interaction between secreted products and cell wall 
anchored surface molecules of the bacterium and the alveolar epithelium together with the 
innate immune system; the bacterium adheres firmly to the tissues through several cell 
surface anchored adhesins, including PsrP and pili. If the bacterium subsequently succeeds 
in "innate inversion" which is the process whereby a pathogenic infection advances from 
mucosal disease to bacteremia the colonization results in a life-threatening condition for the 
host. S. pneumoniae express phosphorylcholine, which can bind to the human platelet-
activating factor receptor (PAFr), as a mean to cross from lung into blood. Mice studies 
show reduced pneumococcal growth and alleviated survival rates when this receptor is 
deleted (2, 9).  
One of the key components of the innate immune system is the pattern-recognition receptors, 
which have evolved to recognize conserved motifs expressed by pathogens, referred to as 
pathogen-associated molecular patterns (PAMPs). One of these pattern-recognition receptors 
is the C-reactive protein, acute-phase protein, is essential during pneumococcal bacteremia as 
it blocks PAFr (2, 9, 57). Indeed, many components of the immune system are active in 
pneumococcal infections, and toll-like receptors (TLRs) are key components as pattern-
recognition receptors in initiation of the cellular innate immune response upon invasion of 
pathogens. This is mainly because they are able to detect a broad range of microbial 
pathogens at e.g. the cell surface. TLRs mediate the recognition of PAMPs and structural 
studies indicate that TLRs recognizes several PAMPs as their ligands (57). TLR2 is most 
commonly thought of as very important in the response to Gram-positive pathogens, and the 
PAMPs recognized by TLR2 are cell-wall components (peptidoglycan, lipoteichoic acids and 
lipoproteins). Pneumolysin is one of the primary toxins in the etiology of inflammatory 
responses and tissue damage in pneumococcal pneumonia, and the receptor involved in the 
proinflammatory effects of pneumolysin is TLR4 (2, 58).  
1.4.1 Keratins: Keratin 10 
Keratins (KRTs) are cytoskeletal intermediary filament (IF) proteins expressed in epithelial 
cells.  There are, in the mammalian genome, over 50 keratin genes identified. Biochemical 
characteristics, such as molecular weight and isoelectric point (pI), determine the 
classification of the KRTs as type I (acidic) or type II (neutral-basic). The type I and type II 
KRTs are almost exclusively co-expressed in the tissues for which the KRTs are 
characteristic and form coiled coil α-helical heteropolymers (59-62). KRTs are important in 
several aspects of the cell, such as size, migration, differentiation and proliferation. More 
effort is being put into typing of KRTs and the role they play throughout the development of 
carcinomas, in this they can be utilized as tools in histopathological diagnosis. There is 
continuing research into understanding the impact of KRTs in the development of tumor 
formation and behavior (63).  
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All KRTs exhibit a tripartite structure consisting of a long α-helical rod domain and non- α-
helical terminal domains, one N-terminal and one C-terminal. The highly conserved 
secondary structure of the rod domain takes the form of a two-stranded coiled-coil, in KRTs a 
heterodimer of type I and type II. This coiled-coil structure is divided into four segments 
called 1A, 1B, 2A, 2B (Figure 4) and are segmented by short linking segments (L1, L12, L2), 
that in turn forms tetramers, octamers (protofibril) and finally keratin filaments (64). 
Previous studies have shown that KRTs are readily available on the surface of epithelial cells, 
rendering them potential docking sites for bacterial adhesins. Specifically, it has been shown 
that KRT10 is expressed on the surface of desquamated human nasal epithelial cells and 
epidermal keratinocytes. The adhesin clumping factor B (ClfB) of Staphylococcus aureus has 
been shown to interact with KRT10, and possibly KRT8, extracted from these types of cells 
(65, 66), while the SRR-1 protein from Streptococcus agalactie interacts with KRT4 on the 
surface of Hep2-cells, derived from human laryngeal carcinoma (67) 
 
 
 
 
Figure 4. Upper panel: Schematic domain organization of keratins. Bottom panel: Example 
structure of a keratin heterodimer, shown here is the crystal structure (PDB ID: 3TNU) of the 2B 
helical domain of coiled coil heterodimer of KRT5 (type II) and KRT14 (type I) (68) 
1.5 SMALL ANGLE X-RAY SCATTERING 
With the structural information regarding macromolecules becoming more extensive, there is 
an increasing demand on structural determination methods to be able to decipher large 
complexes as well as highly disordered proteins. The challenges we are facing will most 
likely not be readily solved by one single biophysical technique. These challenges can be 
faced by combining high-resolution techniques, such as X-ray crystallography and nucleic 
magnetic resonance (NMR) with methods providing lower-resolution information e.g. 
electron microscopy (EM) and small angle scattering (SAS), particularly small angle X-ray 
scattering (SAXS).  
SAXS provides the possibility of sampling huge complexes, multiple conformation samples, 
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flexibility, assembly, disassembly and aggregation etc. The solution technique is a rapid 
method to gain three-dimensional structural information, as the samples mostly are easily 
prepared. On the contrary X-ray crystallography needs well-diffracting crystals, which can be 
difficult to obtain, and has to prepared in such a way that the proteins are subjected to non-
physiological conditions (i.e. precipitants and denaturants). This may alter the conformation 
and other characteristics of the protein. NMR can be unsuitable when proteins and protein 
complexes reach a certain size, though there are of course exceptions. Therefore, it is evident 
that a large fraction of proteins cannot be analyzed using these two methods alone. The 
advantage SAXS allows for is sampling of proteins in near physiological conditions, and the 
capture of real-time structural conformations resulting from slight changes in buffer 
conditions, addition of co-factors etc. The drawback is the loss of detailed information on the 
atomic level, due to the spherical averaging in the scattering profile (69, 70).  
X-ray crystallography and SAXS are principally similar techniques, and most of the hardware 
can be shared between them. The incident X-ray beam is scattered (SAXS) or diffracted (X-
ray crystallography) by the sample and the intensities are measured by an X-ray detector. The 
fundamental difference is the organization of the target molecules during the collection of 
data. Solution scattering is isotropic where the signal from all of the orientations of the 
molecule is relative to one another and to the beam is sampled and averaged together. In X-
ray crystallography, the signal is obtained from highly ordered molecules stabilized within 
the crystal lattice. The information obtained from this method is significantly more detailed 
than of that acquired with SAXS, as it allows for atomic resolution of the resulting model. 
Due to the need of the molecules to be in a specific conformation that aids crystallization of 
the protein, it is believed that for certain multi-domain or inherently flexible proteins, the 
non-physiological conditions used in the crystallization buffer and the restraints put on 
proteins when forced into a rigid state during crystal packing can lead to biologically 
irrelevant conformations (69, 70).  
1.5.1 SAXS data collection and processing 
The scattering signal in SAXS measurements stem from the difference in average electron 
density between the molecules of interest and the bulk solvent (Δ𝜌(𝒓) = 𝜌!"#$%&' − 𝜌!"#$%&', 
where ρ  is the scattering density). The scattering profile of the buffer must be subtracted from 
that of the protein, since the difference is quite small. The measurements are made by 
exposing a protein sample solution to X-rays, and the scattered intensity (I) is recorded. The 
resulting scattering curve is the solvent subtracted intensity as a function of the momentum 
transfer (s, also denoted q) and the scattering angle (s = 4π sinθ/λ, 2θ is the scattering angle, λ 
the wavelength of the incident beam) (Eq. 1), where 𝜌(𝒓) is the electron density, r is the 
vector describing the spatial position and Dmax is the maximum dimension of the protein (71). 
The scattering profile is dependent on the shape and size of the protein, which means that 
different proteins will have a unique scattering signature (72, 73). The intensity is isotropic 
because of the randomly orientation and distribution of particles in solution. For a 
comprehensive review of solution scattering see (69, 74).  
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𝐼 𝑠 = 4𝜋 𝜌 𝒓 ∗ 𝜌(−𝒓)!!"#! !"#(!")!" 𝑟!𝑑𝑟            (1) 𝑝 𝑟 = 𝑟! 𝜌(𝒓) ∗ 𝜌(−𝒓)               (2) 
The Patterson function is the spatially averaged auto-correlation function of the electron 
density. Multiplied by r2 gives the pair distance distribution function, p(r) (Eq. 2). From the 
p(r) we get direct information about the distances between electrons in the scattering 
molecules that are a distance r from each other. The resulting function is displayed as a 
histogram over these distances. The maximum dimension (maximum intraparticle distance), 
Dmax, as well as the radius of gyration (Rg) can be determined from this plot. It can also be 
used to deduce overall shape (globular, elongated) of a protein (75). The Patterson function in 
X-ray crystallography is related to the P(r), but unlike the P(r) the crystallographic Patterson 
function is derived from molecules that are confined in their rotations. This means that the 
three-dimensional information about the inter-atomic vectors is maintained. The Patterson 
function can be used in crystallography to locate the heavy-atoms in the unit cell, which aids 
in the solving of the phase problem (69, 76).  
The radius of gyration (Rg) of a protein is defined as the square root of the average squared 
distance of the collection of electrons from their common particle center of mass (69, 77). Rg 
can be calculated from the scattering curves generated from the radial scattering intensities in 
different ways. The most common is using the Guinier approximation (78) which is measured 
by linear approximation of the slope of the Guinier plot (ln(I(s)) vs. s) at low values for s. The 
range of the data used to calculate this is sRg<1.3 for globular proteins and sRg<0.8 for 
elongated proteins. If the protein is elongated it might be more suitable to calculate the Rg via 
the Debye approximation, as the Guinier approximation is valid over a narrower range for 
these type proteins. Another important parameter that can be extracted from the lowest s 
values is the zero intensity (I(0)), which is the intensity at zero angle, s=0. As this is 
coincident with the direct beam, this value needs to be extrapolated to be determined. I(0) is 
the square of the number of electrons in the particle that is scattering, on an absolute scale, 
and can therefore be used to determine the molecular weight of the protein (69). 
The Kratky plot can be directly calculated from the scattering curve and plotted as: s2I(s) vs. 
s. This can be used in evaluation of the folding in protein samples. Folded domain proteins 
give rise to the shape of a parabola (roughly), and the peak could provide some information 
regarding the size of the protein. However, the Kratky, as is Rg, is shape-dependent and can 
consequently not give absolute information considering molecular weight. When analyzing 
Kratky plots calculated for e.g. random coil peptides, they follow the Porod-Kratky worm-
like chain (WLC) model (79), it is evident that they are lacking the peak characteristic for 
folded proteins. In the large s region they are linear with respect to s. It is important to note 
that for more extended proteins and proteins that comprises smaller folded regions with long 
flexible linkers, the Kratky analysis needs to be more extensive, and in some cases with 
respect to both the folded regions and the regions that can be described by the WLC model. 
For these type proteins it is sometimes necessary to calculate the radius of gyration of the 
cross section (Rc), as well as the length (L) and treat the entire protein according to the WLC 
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model. This is common when analyzing unfolded or intrinsically disordered proteins (IDPs) 
using SAXS (69, 80). 
1.5.2 Data analysis software 
There are many different analysis software and programs to evaluate, analyze and model 
SAXS data. The availability and user compatibility varies, and here only software from the 
ATSAS (© ATSAS team 1991-2014) suite, developed by Svergun and colleagues, will be 
described, as it is readily available and is predominately what has been used in the work 
presented in this thesis.  
Initial data evaluation is usually done through automated analysis pipelines at beam lines, to 
assess the quality of the data, and if re-measurements are required. This includes calculation 
of Rg and I(0) from the Guinier plot, and is mainly to determine whether or not the protein 
sample shows aggregation or interparticle interference. It should be noted that the software 
used is developed for globular proteins mainly, so it is unwise to blindly use the analysis 
performed by the automated pipeline, as the protein might not be completely globular. It is 
always advisable to perform quality checks of the analyzed data.  
PRIMUS (81) is mainly used to handle the experimental 1-D SAS data files. Features include 
averaging, subtraction, scaling, merging, Guinier approximation, calculation of I(0) and Rg 
(globular, flat and rod-type particles), Porod’s volume and the Kratky plot.  
GNOM (71) is used to process SAS data through the regularization technique. It is an indirect 
transform program that requires one-dimensional scattering curves as input files and 
generates the p(r) (monodisperse systems), which in turn can be used to evaluate Dmax, Rg and 
I(0). 
CRYSOL (82) can be used to evaluate the SAS scattering data when there is a known atomic 
structure available. This can also be used reversibly, to evaluate whether the crystal structure 
has the same conformation in solution as in the crystal packing, or if the crystallization 
process has forced the protein into a biologically irrelevant conformation. This program fits 
the atomic structure to the experimental scattering curves.  
Solution structure modeling can be performed with several different programs, depending on 
what protein or system one wants to analyze. When the individual subunits of a protein are 
known, but not how they are positioned relative one another, rigid body modeling can be 
used to get a model of the overall assembly of the complex. SASREF (83) and CORAL (84) 
are two rigid body modeling programs, where SASREF models a complex formed by 
subunits, where the part of the atomic structure is known, against experimental scattering 
data. CORAL, based on SASREF, performs modeling of multidomain protein complexes 
against multiple experimental scattering data sets.  
Ensemble optimization method (EOM) is a program suite used to describe the SAXS data of 
flexible proteins in solution. The program utilizes an ensemble representation of atomic 
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models that allows for flexibility by allowing different conformations of the protein to coexist 
(84, 85). 
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2 AIMS OF THIS THESIS 
The casualties due to pneumococcus, although difficult to estimate, are believed to be in the 
millions every year worldwide. The efficacy of current vaccines is tapering owing to serotype 
switching, and antibiotic resistant strains are increasing in numbers, which creates a dire need 
for novel drug targets such as virulence-related pneumococcal proteins. A primary step 
towards the identification of new drug targets is structural and biochemical characterization 
of key virulence-factors. In this thesis the structural and partly biochemical basis of adhesion 
to KRT10 of the functional basic region (BR) domain of PsrP has been addressed. 
Additionally, the structural and biochemical study of the self-oligomerization of the BR 
domain has been evaluated, and this has been put in context with the very real possibility that 
PsrP is indeed important in pneuomococcal invasiveness. 
 
Another protein that is believed to be of great importance in the virulence of pneumococcus is 
the Gram-positive pilus component RrgC. At the start of this research, this protein had not yet 
been structurally determined, as the last of the pilus components in the pilus of 
pneumococcus. The aim was to determine the three-dimensional structure of RrgC, 
preferably with X-ray crystallography, and to assess the function through small-angle X-ray 
scattering. This protein proved difficult to crystallize, which can be explained by the SAXS 
data collected and analyzed, as well as from recently published data regarding the structure 
(35). I present in this thesis the structural basis of this protein in solution.  
 
The aims of the thesis was to investigate important virulence factors by structural studies, 
using X-ray crystallography and small angle X-ray scattering, as well as biochemical studies.
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3 RESULTS AND DISCUSSION 
3.1 STRUCTURAL STUDIES OF THE BASIC REGION (BR) OF PSRP AND ITS 
BINDING TO KERATIN 10 (PAPER I) 
The pneumococcal serine-rich repeat protein (PsrP) is one of the key virulence factors 
naturally occurring in a majority of strains capable of causing IDP. The functional BR binds 
to KRT10 and is suggested to play a pivotal role in biofilm formation through self-
oligomerization. In this study we present the crystal structure of BR187-385, the KRT10 binding 
portion of BR (paper I; figure 1a), determined to 2.0 Å resolution. Structural homology 
analysis reveals a novel variant of the DEv-IgG fold. This fold is typical in MSCRAMMs 
(Microbial surface components recognizing adhesive matrix molecule), the adhesive 
molecules commonly found in Gram-positive bacteria. The structure, a compressed two-sided 
β-barrel, presents a basic groove on the one side of the barrel that is likely to interact with the 
acidic rod domain of KRT10. The other side of the barrel, formed by a loop region 
interspersed with short, stabilizing β-strands, contains the specific binding site for interaction 
with the tail-rod domain of KRT10. 
3.1.1 The KRT10 binding region domain of PsrP adopts a MSCRAMM-type 
fold 
The overall three-dimensional structure of BR187-385 can be described as a compressed β-
barrel, with two very different faces (paper I; figure 1b). The β-barrel consists of one 
extended twisted β-sheet oppose a distorted β-sheet interspersed with loops and β-turns. 
Structural homology search reveals that the fold BR187-385 adopts is related to the DEv-IgG 
fold, an MSCRAMM fold-variant (paper I; figure 3). The typical topology of this fold can 
be crudely described as a compressed β-barrel comprising two opposing β-sheets. The fold 
of BR187-385 is a novel variant of this type of fold. A Dali search (86) identified nine structural 
homologues belonging to the MSCRAMM or SRRP family (paper I; table S2).  
Analytical ultracentrifugation (AUC) confirms a monomer in solution, with a sedimentation 
coefficient of 1.85 S that corresponds to a monomer with a hydrodynamic radius of 25 Å 
(paper I; figure 2a). Using size exclusion chromatography (SEC, data not shown), a similar 
value of the hydrodynamic radius was derived from the retention volume of the BR187-385 
monomer. Finally, SAXS data collection was performed in order to further establish the 
monomeric form of BR187-385 in solution. Analysis of the data collected clearly shows a 
monomer in solution (paper I; figure 2b; table S1). The concave touchdown observed in 
the p(r) suggests some elongation and/or several different conformations in solution (80), 
probably due to some disorder in the N-terminal part of the protein. The experimental 
SAXS data was subjected to EOM, and the results indicate that the protein construct is 
globular with N- and C-terminal flexible extensions (paper I; figure S1).  
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3.1.2 The KRT10 binding pocket of BR187-385 bares resemblance to a paperclip 
The residues 273-341 of PsrP comprise the KRT10 binding region. Within this region there 
is a substructure that resembles the form of a paperclip, with a front and back (paper I; 
figure 4a). Previously reported experimental data states that only BR constructs containing 
the entire sequence for KRT10 binding were able to inhibit binding of TIGR4 to 
KRT10+A549 cells (32), which these structural findings might explain. Examination of the 
distribution of the B-factor values suggests a high flexibility in the loops of LC1/C2, LD1/D2 
and LD3/D4 compared to the rest of the structure, which is more rigid (paper I; figure 4a; 
figure S4a). Conformational rearrangements of these loops might be required in order to 
accommodate KRT10.  
The glycine loops of KRT10 are intrinsically disordered protein regions, and interactions 
with these type regions require hydrophobic interactions (87). When analyzing the surface 
regions of BR187 – 385 two distinct hydrophobic patches can be found (paper I; figure 4b). 
These pockets might act as the initial anchor points for interaction. Furthermore, analysis of 
the electrostatic surface of BR187 – 385 unveiled a highly basic groove (paper I; figure 4c). It 
is possible for the acidic helical rod domain of KRT10 to fit in this groove (paper I; figure 
S5). The initial complex formation between BR187 – 385 and the acidic heterodimer of 
KRT10/KRT1 may be due to the electro-static forces owing to the complementary charges 
on each molecule (67).  
3.1.3 Alanine substitution of several residues within the paperclip-like 
region of BR187-385 disrupts binding to KRT10 
A pull-down experiment using Strep-Tag-II BR187 – 385 (STII-BR187 – 385) bound to Ni–NTA 
bead-immobilized full- length KRT10 confirmed that there is interaction between BR187 – 385 
and KRT10 (paper I; figure 5a). In order to investigate the specific site of interaction in 
KRT10, three truncated constructs of KRT10 were designed and produced (paper II; figure 
5b); head rod domain (HRD), tail rod domain (TRD) and rod domain (ROD). These 
constructs were tested for interaction with STII-BR187 – 385 in ELISA assays and while the 
binding capacity was similar for KRT10 full-length (FL) and KRT10-TRD, KRT10-ROD 
bound significantly less, and binding to KRT-HRD was even lower still (paper I; figure 5b). 
The head and tail domains of KRT10 both contain glycine-rich tandem repeats, that can be 
described as loops held together by aromatic residues and/or large nonpolar residues. The tail 
domain of KRT10 has been suggested to contain more flexible glycine loops and this could 
be important in its interaction with other proteins (62, 88, 89). Using the peptide-binding 
prediction site, PepSite (90), two sites, associated with the ‘paperclip’, were identified in 
BR187 – 385, where several possible LPMs from KRT10 could bind (paper I; figure S6). 
These two predicted sites were used in the design of a mutation study, where ten residues, 
within or close to these sites, were substituted to alanine (paper I; figure 6a). The mutants 
were then subjected to ELISA, to test the ability to bind KRT10-TRD.  
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Circular dichroism (CD) performed on all the mutants, and the BR187 –385 for comparison, 
showed no significant change in the overall secondary structure, and in the production nor 
purification by SEC, were any changes devisable. Although it should be noted that the 
introduced substitutions might have induced small conformational changes, not detectible 
by CD, that may have had implications of the binding to KRT10-TRD. 
 18 
3.2 THE BASIC REGION (BR) OF PSRP HOLDS A FURIN PROTEASE 
CLEAVAGE SITE AND FORMS A DIMER THAT MAY BE IMPORTANT IN 
BIOFILM FORMATION (PAPER II, MANUSCRIPT) 
The proposed self-oligomerization region of PsrP is localized in the N-terminal region of the 
BR domain. We have, however, found that the KRT10-binding BR187-385, lacking this N-
terminal part, forms stable higher oligomers in vitro. We show that this N-terminal region is 
non-globular and probably disordered through SAXS and circular dichroism (CD). In this 
study we perform a comparative analysis of the long and short constructs of the BR domain 
of PsrP (BR120-395 and BR187-385, respectively). The results suggest a possibility that the N-
terminal region might even play an inhibitory role in the self-oligomerization of BR. We 
discovered a sequence localized between the globular domain of BR (BR187-385) and the 
disordered N-terminal region which is recognized by the human furin protease. Cleavage by 
this protease releases the N-terminal part, which could be a mechanism of activation of 
oligomerization of PsrP.  
3.2.1 BR120-395 carries the previously reported self-oligomerizing portion, but 
forms a lesser amount of oligomers than the shorter BR187-385 domain 
When produced in Escherichia coli both constructs of the BR domain forms higher oligomers 
in addition to the monomeric form. This was unexpected considering that the putative 
oligomerization domain was supposed to be situated in the N-terminal part of BR120-395 (32), 
and not present in BR187-385.  
The monomeric form of BR187 – 385 has recently been structurally determined (91). However, 
during production of the monomeric form we observed higher oligomers during isolation of 
the monomer using size exclusion chromatography (SEC), (paper II, figure 1B). 
Investigation of these oligomers showed that they are stable and static, i.e. did not convert 
back to monomeric form when re-applied on the SEC-column (figure 5). The longer 
construct, BR120-395, forms a lower proportion of oligomers than the construct lacking the 
oligomerization region (figure 5), (paper II, figure 1C). 
  
Figure 5. BR187-385 forms a higher portion of higher oligomeric states than the longer BR120-395, which 
carries the putative oligomerization domain. The figure shows the chromatograms (SEC) from re-
application of isolated monomer and oligomer from (left panel) short construct BR187-385 and (right 
panel) long construct BR120-395 
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3.2.2 N-terminal part of BR120-395 comprising the putative self-oligomerizing 
region resembles the structure of an IDP 
When subjected to bioinformatic analysis, the N-terminal part of BR120-395, the sequence 
comprising residues 120-170, was predicted to be disordered (paper II; supplementary 
material; figure S1A).  
In order to further investigate the disordered N-terminal region of BR120-395, a comparative 
SAXS study was performed between the longer and shorter constructs (paper II; figure 
2A,B; table 1). When analyzing the scattering curves for each construct, it is immediately 
evident that the shape of the longer construct is less globular than the shorter construct. This 
was expected since we believe that the N-terminal region of BR120-395 is disordered, and 
though the globular domain of BR187-385 remains, the overall structure will display more 
flexible and elongated properties (figure 6). The particle distance distribution function, p(r), 
(paper II; figure 2C) gives Dmax values of 12.5 ± 1.2 nm and 7.8 ± 0.8 nm for BR120-395 and 
BR187-385, respectively. Although it should be noted that when performing the analysis 
manually (analysis of the scattering data by the indirect Fourier transform method using 
GNOM (71)), we found that Dmax values in the range 12 - 18 nm were probable within 
reasonable degrees of agreement (χ2≤1) for BR120-395. This would suggest that the protein 
construct takes many different conformations in solution, which is not surprising considering 
the predicted disorder of the long N-terminal region. Another indication that the protein is 
elongated and/or takes many different conformations in solution is the concave touchdown of 
the p(r), for completely globular proteins this would be smooth and convex (80). The peak of 
BR120-395 appears at a slightly longer distance than BR187-385, further supporting the theory that 
the longer construct appears predominately in a more elongated state in solution.  
 
 
Figure 5 Experimental scattering curves of BR187-385 (grey) and of BR120-395 (black). Already here we 
can see the difference between the constructs in that the curve of the short construct (grey) adopts a 
more backwards s-shaped curve than does the longer construct. This indicates a more globular shape 
for BR187-385 than for BR120-395. 
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3.2.3 The N-terminal region of BR120-395 is released by cleavage of Furin 
protease 
As previously mentioned, the shorter construct, BR187-385, forms a higher portion of oligomeric 
forms than does the longer construct, BR120-395. This might be an indication that the N-
terminal part in some way hinders effective oligomerization of BR120-395. Interestingly 
enough, five positive residues in a stretch (K164RRKR168) were found in between the KRT10 
binding region and the non-globular N-terminal region (paper II; figure 1A). The sequence 
comprises sequence motif R-X-K/R-R that is specifically recognized by ubiquitously 
expressed furin-like proteases. It is well known that furin proteases activate several pro-
protein substrates as well as bacterial and viral pathogenic agents (92-94). Protease cleavage 
assays confirmed that the N-terminal part could be readily cleaved off BR120-395 at the 
predicted position by human furin protease. The proteolytic activity could be inhibited when 
a furin-specific inhibitor was present. Moreover, a mutated construct of BR120-395, where two 
arginines where serine substituted (BR*120-395, KRRKR → KSRKS) was produced. The furin 
protease was unable to cleave off the N-terminal region on the mutant. 
A previous study has recently shown that PsrP is capable of self-oligomerization through the 
BR-domain for pneumococcal biofilm formation (95). Based on these results, we 
hypothesized that the human, or possibly a putative pneumococcal, furin protease cleaves the 
N-terminal disordered region off PsrP in order to initiate biofilm formation through self-
oligomerization. Microbial biofilms consists mainly of microorganisms adhering to a surface 
and embedded in exopolysaccharides. Sometimes these are bound together by nucleic acids, 
lipids and proteins (24, 96), to which the N-terminal region of PsrP might contribute when 
cleaved from the rest of the protein. 
3.2.4 The crystal structure of the BR187-385 dimer unveils 3D domain 
swapping 
In order to investigate the stable dimer formation of the BR187-385, crystallization trials were 
set up. However, the crystals obtained proved difficult to reproduce and diffracted poorly. To 
combat this, a shorter construct was designed and produced. The residues removed were the 
seven C-terminal residues not built in the model of monomeric BR187-385, due to missing 
electron density (91). The final model shows a dimer structure with two subdomains, each 
resembling the structure of the BR187-385 monomer (paper II; figure 5A and 5B). 
The crystal structure reveals that the dimer is formed through a 3D domain swap, a well-
established mechanism for proteins to form oligomers from their monomers (97). In the 
BR187-385 dimer, the domain swap comprises β-strands from one chain forming a new β-sheet 
with β-strands from the neighboring chain (paper II; figure 6A). The release of proteases and 
chaperones during forming of the biofilm matrix might also aid in the domain swapping 
process. The hypothesis we are working with is that the domain-swapped BR187-385 dimer 
could be relevant in establishing stable cell-cell contacts during biofilm formation, and it is 
possible that the BR domain could form even higher complexes through this mechanism as 
well. 
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SAXS data collected for the BR187-385 dimer correspond reasonably well to the structure of 
the BR187-378 dimer. Analysis of the data indicated an overall butterfly-like shape, with two 
distinct domains. Dmax values of 9.2 ± 0.9 nm were derived from the p(r), which displays a 
maximum at 2.5 nm with a shoulder at 4.2 nm (paper II; figure S2). It should be noted that 
as for the longer construct BR120-395, when performing the analysis manually (analysis of the 
scattering data by the indirect Fourier transform method using GNOM (71)), we found that 
Dmax values in the range 9 - 12 nm were probable within reasonable degrees of agreement 
(χ2≤1). Although this would suggest a lesser degree of conformational diversity in solution 
than for BR120-395, it is considerably more than in the shorter BR187-385 construct. 
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3.3 STRUCTURAL ANALYSIS OF THE MINOR ANCILLARY PILUS PROTEIN 
RrgC IN SOLUTION 
There have been many questions regarding the minor ancillary pilus protein RrgC, and 
therefor much effort has gone into researching this final component of the pneumococcal 
pilus. As results previous studies have been somewhat contradictory, the need to structurally 
determine this protein has been great. Secondary structure predictions suggested that RrgC 
consists of three domains with disordered loop regions between the domains. In this study, 
we designed a protein construct where the N-terminal signaling peptide and the hydrophobic 
tail, the CWSS, were removed. The resulting protein could be expressed and purified as a 
soluble protein. RrgC was studied with SAXS, and the analysis showed a protein comprising 
short structural elements with flexible linkers, consistent with the structure predictions. 
Recently, the structure of a mutated full-length RrgC has been solved with X-ray 
crystallography, and analysis with CRYSOL revealed a nice fit of the determined crystal 
structure to the experimental SAXS data collected in this study. 
3.3.1 SAXS analysis reveals that RrgC adopts an elongated shape in 
solution. 
The protein construct used in this study was designed based on the full-length RrgC, which 
will be called RrgC. The N-terminal signal peptide and the C-terminal hydrophobic CWSS 
were omitted in order to acquire a protein construct that could be readily expressed and 
purified as a soluble protein, and to facilitate crystallization trials as well as SAXS analysis. 
SAXS experiments and subsequent analysis reveals a protein with an elongated rod shape in 
solution, most probably containing several structural elements with flexible regions. Structure 
prediction using Phyre2 (98) and PsiPred (99, 100) show that RrgC most probably consists of 
three domains with long flexible, possibly disordered, linkers between them. 
Analysis of the scattering curve together with the p(r) and the Kratky plot (figure 7) suggests 
that RrgC is a multidomain protein with characteristics associated to that of a protein 
comprising smaller domains with flexible linkers, possibly disordered, in solution. The fact 
that the protein is multi-domain is perhaps most visible in the p(r), with a maximum peak at 
2.3 nm, and two shoulders at 4.7 and 7.4 nm (80). The Dmax values of 12-13.2 nm were 
probable, suggesting the inherent flexibility and possible conformational diversity of the 
protein in solution. The Kratky for RrgC is plotted together with the Kratkys for a completely 
globular protein, as well as a completely extended protein chain, for emphasis. As is clearly 
visible, the RrgC adopts a conformation in solution more closely related to that of a 
completely extended protein. The Kratky curves for a globular and extended protein were 
calculated (80).  
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Figure 6. Top panel shows the buffer-subtracted scattering curve for RrgC, and the middle panel 
shows the p(r), here for Dmax=13. The bottom panel shows the Kratky plot with reduced coordinates 
Crystallization trials of RrgC failed, and a mutated version of the full-length RrgC has now 
been structurally solved (35). In this study, the efforts of trying to crystallize the basic same 
construct as was designed in our study were unsuccessful. A surface entropy reduction 
analysis suggested three mutations; Glu-179, Lys-180, Glu-181 into alanines, which is the 
construct that successfully crystallized. The crystal structure fits nicely with the SAXS data 
presented here (figure 8), suggesting that the structure contains three domains and takes an 
elongated rod-like shape in solution. 
3.3.2 Experimental procedures 
3.3.2.1 Protein production and purification 
The coding sequence of the wild type full-length RrgC was obtained from S. pneumoniae 
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TIGR4 (T4) strain chromosomal DNA as previously described (39). The DNA encoding 
residues 29-268 of the protein RrgC was cloned into the pET21d expression vector 
(Novagen) using the Fastcloning method (101). The resulting construct containing a C-
terminal poly-histidine (HHHHHH) tag was transformed into E. coli (T7 express, New 
England Biolabs) for over-expression at 37°C. Protein expression was induced at OD 0.4-07 
with isopropyl-D-1-thiogalacto-pyranoside and cultures were maintained at 25°C overnight.  
 
 
Figure 7. Top panel shows the CRYSOL fit of the crystal structure of RrgC (PDB-ID 4OQ1), Χ2=1.00. 
Bottom panel depicts the structural envelope for RrgC as modeled ab initio by DAMMIF, 
superimposed on the crystal structure of RrgC (PDB-ID 4OQ1). Figure created using PyMOL version 
1.3 (56) 
The poly-histidine-tagged RrgC29-268 was purified from cell culture lysate using immobilized 
metal affinity (IMAC) chromatography (HisTrap FF; GE Healthcare) and in a second step 
SEC, where the protein was loaded on Superdex 75 or 200 columns (GE Healthcare). The 
purity of <98% was assessed using SDS-PAGE (data not shown) and later confirmed as pure 
and monodisperse sample with dynamic light scattering (DLS) and SAXS experiments.  
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3.3.2.2 Small angle X-ray scattering 
Sample preparation and data collection. Data sets were collected at beamline 29 (BioSAXS) 
at the European Synchrotron Radiation Facility (ESRF, Grenoble) (102). Prior to data 
collection, protein samples were buffer exchanged into phosphate buffered saline (PBS) with 
5% glycerol, pH 7.4. Samples were measured at concentrations between 0.3 and 3 mg/ml 
using a continuous flow cell capillary. Each experimental run was carried out in duplicates in 
order to evaluate systematic error in the data. 
Data analysis. Scattering curves of the buffer was subtracted from each individual protein 
scattering curves to decimate scattering contributions from the buffer solution. The Rg value 
(3.55 ± 0.03) were obtained from the Guinier plot (sRg limit: 0.358-1.101), and the theoretical 
curve was generated using CRYSOL (82) from the crystal structure of RrgC (PDB-ID: 4OQ1 
(35)). The p(r) was calculated using GNOM (71). The Dmax values were obtained from the 
p(r) by running GNOM with varying Dmax values and Dmax values in the range 12 – 13.2 nm 
were probable within reasonable degrees of agreement (χ2≤1). 
The ab initio shape reconstruction was performed using DAMMIF (103), was not constrained 
to any symmetry (P1) and was run twenty times in order to assess the reproducibility of the 
model reconstruction. The twenty similar, separate 3D structure models obtained were 
spatially aligned and analyzed for spatial discrepancy using SUPCOMB (104). Models that 
are dissimilar were rejected and a model representing the volume most populated among the 
twenty models is presented (figure 8).  
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4 CONCLUDING REMARKS 
The focus of this thesis is the structural elucidation of the function of pneumococcal virulence 
factors; more specifically the pneumococcal serine-rich repeat protein, PsrP, and the minor 
ancillary pilus component, RrgC. In order to achieve a greater understanding of the part these 
proteins play in pneumococcal invasion, a structural approach, involving X-ray 
crystallography and SAXS, was combined with biochemical methods. 
We have shown that the basic region, BR, of Psrp, in its function as an adhesin, is able to 
interact specifically with the tail rod domain region of keratin 10 and that the most probable 
mechanism of action is a two-step binding process. This interaction with a human protein is 
one of several, perhaps many, possible interaction partners for PsrP throughout an S. 
pneumonia infection. This latching to host tissue may be the first step in pneumococcal 
invasive disease. The next step could be the formation of biofilm in order to consolidate the 
hold of infection. Incidentally, the putative oligomerization region of the BR domain has been 
scrutinized as part of this work. The crystal structure of a dimer not containing this region 
show that BR is able to oligomerize through the mechanism of domain swapping. This 
together with the fact that the BR domain contains a Furin protease cleavage recognition 
sequence betwixt the oligomerization and keratin 10 binding region suggests the possibility 
of a trigger of oligomerization through proteolytic cleavage.  
The three-dimensional structure of RrgC has been unknown until recently, and previous 
reports of this protein have been contradictory. In this thesis we report the structural envelope 
of this protein, as determined by SAXS, which reveals an elongated, flexible protein in 
solution. The flexible linkers between the domains provide the possibility of many different 
conformations in solution. The crystal structure recently published, confirms the SAXS data 
presented here.  
These findings will aid in the future work towards development of novel vaccines and drugs 
in the quest for abolishment of this microorganisms hold on humanity. 
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